| 1 | interactions | 8,703 |
| 2 | inter-actions | 361 |
| 3 | h-bonds | 45 |
| 4 | faults | 44 |
| 5 | repulsion | 41 |
| 6 | inter-action | 37 |
| 7 | cross-reactions | 20 |
| 8 | interchanges | 8 |
| 9 | repulsions | 8 |
| 10 | aziridines | 5 |
| 11 | target-guided | 4 |
| 12 | differences.the | 3 |
| 13 | reimbursability | 3 |
| 14 | energetic/redox | 2 |
| 15 | layer-structured | 2 |
| 16 | methylammonium | 2 |
| 17 | nanogeometries | 2 |
| 18 | plakophilin-3/gfp | 2 |
| 19 | superhelices | 2 |
| 20 | transactivations | 2 |
| 21 | acid-8-o-β-d-glucopyranoside | 1 |
| 22 | behavior-may | 1 |
| 23 | biophases | 1 |
| 24 | cav2o4 | 1 |
| 25 | de-synchronization | 1 |
| 26 | dyselectrolytemia | 1 |
| 27 | factors-'breakfast | 1 |
| 28 | factors.conclusions | 1 |
| 29 | factors/mechanisms | 1 |
| 30 | fdxs | 1 |
| 31 | fervent | 1 |
| 32 | flavonoid-derivatives | 1 |
| 33 | grappling | 1 |
| 34 | inter-ations | 1 |
| 35 | interactions.a | 1 |
| 36 | kna3 | 1 |
| 37 | manor | 1 |
| 38 | nanogap | 1 |
| 39 | nanostuctures | 1 |
| 40 | outcome-heterozygous | 1 |
| 41 | o⋯h-c | 1 |
| 42 | pair-formulae | 1 |
| 43 | piperidino-pyrrolizidines | 1 |
| 44 | polycycles | 1 |
| 45 | reaction/rash | 1 |
| 46 | reagents/kits | 1 |
| 47 | realignments | 1 |
| 48 | solvatomorphs | 1 |
| 49 | spiro-frameworks | 1 |
| 50 | structures/architectures | 1 |
| 51 | syninclusions | 1 |
| 52 | tears/maceration | 1 |
| 53 | trophozoites/cysts | 1 |
| 54 | tumours/resections | 1 |
| 55 | δ-1 | 1 |
| 56 | λ-2 | 1 |
| 1 | acid-8-o-β-d-glucopyranoside | 1 |
| 2 | aziridines | 5 |
| 3 | behavior-may | 1 |
| 4 | biophases | 1 |
| 5 | cav2o4 | 1 |
| 6 | cross-reactions | 20 |
| 7 | de-synchronization | 1 |
| 8 | differences.the | 3 |
| 9 | dyselectrolytemia | 1 |
| 10 | energetic/redox | 2 |
| 11 | factors-'breakfast | 1 |
| 12 | factors.conclusions | 1 |
| 13 | factors/mechanisms | 1 |
| 14 | faults | 44 |
| 15 | fdxs | 1 |
| 16 | fervent | 1 |
| 17 | flavonoid-derivatives | 1 |
| 18 | grappling | 1 |
| 19 | h-bonds | 45 |
| 20 | inter-action | 37 |
| 21 | inter-actions | 361 |
| 22 | inter-ations | 1 |
| 23 | interactions | 8,703 |
| 24 | interactions.a | 1 |
| 25 | interchanges | 8 |
| 26 | kna3 | 1 |
| 27 | layer-structured | 2 |
| 28 | manor | 1 |
| 29 | methylammonium | 2 |
| 30 | nanogap | 1 |
| 31 | nanogeometries | 2 |
| 32 | nanostuctures | 1 |
| 33 | outcome-heterozygous | 1 |
| 34 | o⋯h-c | 1 |
| 35 | pair-formulae | 1 |
| 36 | piperidino-pyrrolizidines | 1 |
| 37 | plakophilin-3/gfp | 2 |
| 38 | polycycles | 1 |
| 39 | reaction/rash | 1 |
| 40 | reagents/kits | 1 |
| 41 | realignments | 1 |
| 42 | reimbursability | 3 |
| 43 | repulsion | 41 |
| 44 | repulsions | 8 |
| 45 | solvatomorphs | 1 |
| 46 | spiro-frameworks | 1 |
| 47 | structures/architectures | 1 |
| 48 | superhelices | 2 |
| 49 | syninclusions | 1 |
| 50 | target-guided | 4 |
| 51 | tears/maceration | 1 |
| 52 | transactivations | 2 |
| 53 | trophozoites/cysts | 1 |
| 54 | tumours/resections | 1 |
| 55 | δ-1 | 1 |
| 56 | λ-2 | 1 |
| 1 | δ-1 | 1 |
| 2 | λ-2 | 1 |
| 3 | kna3 | 1 |
| 4 | cav2o4 | 1 |
| 5 | interactions.a | 1 |
| 6 | dyselectrolytemia | 1 |
| 7 | o⋯h-c | 1 |
| 8 | target-guided | 4 |
| 9 | layer-structured | 2 |
| 10 | pair-formulae | 1 |
| 11 | acid-8-o-β-d-glucopyranoside | 1 |
| 12 | differences.the | 3 |
| 13 | grappling | 1 |
| 14 | reaction/rash | 1 |
| 15 | methylammonium | 2 |
| 16 | repulsion | 41 |
| 17 | tears/maceration | 1 |
| 18 | de-synchronization | 1 |
| 19 | inter-action | 37 |
| 20 | nanogap | 1 |
| 21 | plakophilin-3/gfp | 2 |
| 22 | manor | 1 |
| 23 | h-bonds | 45 |
| 24 | superhelices | 2 |
| 25 | interchanges | 8 |
| 26 | nanogeometries | 2 |
| 27 | polycycles | 1 |
| 28 | aziridines | 5 |
| 29 | piperidino-pyrrolizidines | 1 |
| 30 | structures/architectures | 1 |
| 31 | nanostuctures | 1 |
| 32 | biophases | 1 |
| 33 | flavonoid-derivatives | 1 |
| 34 | solvatomorphs | 1 |
| 35 | spiro-frameworks | 1 |
| 36 | factors/mechanisms | 1 |
| 37 | repulsions | 8 |
| 38 | syninclusions | 1 |
| 39 | factors.conclusions | 1 |
| 40 | inter-ations | 1 |
| 41 | transactivations | 2 |
| 42 | inter-actions | 361 |
| 43 | cross-reactions | 20 |
| 44 | interactions | 8,703 |
| 45 | tumours/resections | 1 |
| 46 | reagents/kits | 1 |
| 47 | faults | 44 |
| 48 | realignments | 1 |
| 49 | trophozoites/cysts | 1 |
| 50 | outcome-heterozygous | 1 |
| 51 | fdxs | 1 |
| 52 | fervent | 1 |
| 53 | factors-'breakfast | 1 |
| 54 | energetic/redox | 2 |
| 55 | behavior-may | 1 |
| 56 | reimbursability | 3 |